© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
February 14, 2022
Closing their discussion on insomnia, panelists share final thoughts and advice for community physicians.
Expert panelists share their excitement for novel agents that may impact the insomnia treatment landscape.
February 07, 2022
A brief review of the unmet needs in insomnia management, particularly access to treatment and daytime functioning.
Practical considerations for selecting a particular agent or class when treating a patient with insomnia.
Daridorexant Provides Positive Phase 3 Results in Adults with Insomnia
Pandemic-Trauma Stress Symptoms: Nightmares Significantly Increased Among Adults
AI Algorithm May Help Identify Eligibility for Diabetic Retinopathy Clinical Trials